Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Neoplasms of the CNS

  Free Subscription


Articles published in J Clin Oncol

Retrieve available abstracts of 83 articles:
HTML format



Single Articles


    June 2024
  1. YU Y, Miao E, Pike LRG
    Improved CNS Control With the Addition of Chemotherapy to Osimertinib: A Devil's Bargain?
    J Clin Oncol. 2024;42:2107-2108.
    PubMed    


  2. KOTECHA R, Schiff D, Chakravarti A, Fleming JL, et al
    Multidisciplinary Management of Isocitrate Dehydrogenase-Mutated Gliomas in a Contemporary Molecularly Defined Era.
    J Clin Oncol. 2024 Jun 4:JCO2302195. doi: 10.1200/JCO.23.02195.
    PubMed     Abstract available


  3. MIKOLAJEWICZ N, Yee PP, Bhanja D, Trifoi M, et al
    Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical Application.
    J Clin Oncol. 2024;42:1961-1974.
    PubMed     Abstract available


    March 2024
  4. XIAO H, Vaidya R, Hershman DL, Unger JM, et al
    Impact of Broadening Trial Eligibility Criteria on the Inclusion of Patients With Brain Metastases in Cancer Clinical Trials: Time Series Analyses for 2012-2022.
    J Clin Oncol. 2024 Mar 27:JCO2301777. doi: 10.1200/JCO.23.01777.
    PubMed     Abstract available


    February 2024
  5. MARGOL AS, Molinaro AM, Onar-Thomas A, Resnick A, et al
    Use of External Control Cohorts in Pediatric Brain Tumor Clinical Trials.
    J Clin Oncol. 2024 Feb 23:JCO2301084. doi: 10.1200/JCO.23.01084.
    PubMed     Abstract available


  6. WU J, Heidelberg RE, Gajjar A
    Adolescents and Young Adults With Cancer: CNS Tumors.
    J Clin Oncol. 2024;42:686-695.
    PubMed     Abstract available


  7. ARRILLAGA-ROMANY I, Gardner SL, Odia Y, Aguilera D, et al
    ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma.
    J Clin Oncol. 2024 Feb 9:JCO2301134. doi: 10.1200/JCO.23.01134.
    PubMed     Abstract available


    December 2023
  8. DE VIS JB, Cmelak AJ, Osmundson EC
    Chemoimmunotherapy for Untreated Lung Cancer Brain Metastases: Systemic Before Local Therapy?
    J Clin Oncol. 2023 Dec 11:JCO2302151. doi: 10.1200/JCO.23.02151.
    PubMed    


  9. LEHRER EJ, Trifiletti DM, Fadul CE, Brown PD, et al
    Chemoimmunotherapy for Untreated Lung Cancer Brain Metastases: A Reason for Optimism While Avoiding Overreaching Interpretations.
    J Clin Oncol. 2023 Dec 11:JCO2301876. doi: 10.1200/JCO.23.01876.
    PubMed    


  10. JANNE PA, Planchard D, Kobayashi K, Cheng Y, et al
    CNS Efficacy of Osimertinib With or Without Chemotherapy in Epidermal Growth Factor Receptor-Mutated Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2023 Dec 2:JCO2302219. doi: 10.1200/JCO.23.02219.
    PubMed     Abstract available


    November 2023
  11. HAAS-KOGAN DA, Aboian MS, Minturn JE, Leary SES, et al
    Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial.
    J Clin Oncol. 2023 Nov 17:JCO2301838. doi: 10.1200/JCO.23.01838.
    PubMed     Abstract available


  12. RUDIN CM, Liu SV, Soo RA, Lu S, et al
    SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer.
    J Clin Oncol. 2023 Nov 17:JCO2301363. doi: 10.1200/JCO.23.01363.
    PubMed     Abstract available


  13. FRIEDMAN HS, Prados MD, Wen PY, Mikkelsen T, et al
    Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma.
    J Clin Oncol. 2023;41:4945-4952.
    PubMed     Abstract available


  14. MELLINGHOFF IK
    Flashback Foreword: Bevacizumab and Irinotecan in Recurrent Glioblastoma.
    J Clin Oncol. 2023;41:4943-4944.
    PubMed    


    October 2023
  15. LEWIS KL, Jakobsen LH, Villa D, Smedby KE, et al
    High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma.
    J Clin Oncol. 2023 Oct 5:JCO2300365. doi: 10.1200/JCO.23.00365.
    PubMed     Abstract available


    September 2023
  16. WEN PY, van den Bent M, Youssef G, Cloughesy TF, et al
    RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults.
    J Clin Oncol. 2023 Sep 29:JCO2301059. doi: 10.1200/JCO.23.01059.
    PubMed     Abstract available


  17. BANU MA, McKhann GM
    Maximizing Extent of Resection for Noneloquent Glioblastoma: Fluorescent Dye or Intraoperative Magnetic Resonance Imaging?
    J Clin Oncol. 2023 Sep 18:JCO2300963. doi: 10.1200/JCO.23.00963.
    PubMed    


  18. RAHMAN R, Trippa L, Lee EQ, Arrillaga-Romany I, et al
    Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization.
    J Clin Oncol. 2023 Sep 18:JCO2300493. doi: 10.1200/JCO.23.00493.
    PubMed     Abstract available


    August 2023
  19. HARGRAVE DR, Terashima K, Hara J, Kordes UR, et al
    Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory BRAF V600-Mutant Pediatric High-Grade Glioma.
    J Clin Oncol. 2023 Aug 29:JCO2300558. doi: 10.1200/JCO.23.00558.
    PubMed     Abstract available


  20. LU BY, Goldberg SB
    Chemoimmunotherapy for Untreated Lung Cancer Brain Metastases: Systemic Before Local Therapy?
    J Clin Oncol. 2023 Aug 21:JCO2301323. doi: 10.1200/JCO.23.01323.
    PubMed    


  21. NADAL E, Rodriguez-Abreu D, Simo M, Massuti B, et al
    Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05).
    J Clin Oncol. 2023 Aug 21:JCO2202561. doi: 10.1200/JCO.22.02561.
    PubMed     Abstract available


    June 2023
  22. RODER C, Stummer W, Coburger J, Scherer M, et al
    Intraoperative MRI-Guided Resection Is Not Superior to 5-Aminolevulinic Acid Guidance in Newly Diagnosed Glioblastoma: A Prospective Controlled Multicenter Clinical Trial.
    J Clin Oncol. 2023 Jun 19:JCO2201862. doi: 10.1200/JCO.22.01862.
    PubMed     Abstract available


  23. NEGRAO MV, Spira AI, Heist RS, Janne PA, et al
    Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With KRAS(G12C)-Mutated Non-Small-Cell Lung Cancer Who Have Untreated CNS Metastases.
    J Clin Oncol. 2023 Jun 16:JCO2300046. doi: 10.1200/JCO.23.00046.
    PubMed     Abstract available


  24. DUMMER R, Corrie P, Gutzmer R, Meniawy TM, et al
    First-Line, Fixed-Duration Nivolumab Plus Ipilimumab Followed by Nivolumab in Clinically Diverse Patient Populations With Unresectable Stage III or IV Melanoma: CheckMate 401.
    J Clin Oncol. 2023 Jun 12:JCO2202199. doi: 10.1200/JCO.22.02199.
    PubMed     Abstract available


    May 2023
  25. WARREN KE, Vezina G, Krailo M, Springer L, et al
    Phase II Randomized Trial of Lenalidomide in Children With Pilocytic Astrocytomas and Optic Pathway Gliomas: A Report From the Children's Oncology Group.
    J Clin Oncol. 2023 May 1:JCO2201777. doi: 10.1200/JCO.22.01777.
    PubMed     Abstract available


    April 2023
  26. HSU TW, Liang CS, Tsai SJ, Bai YM, et al
    Risk of Major Psychiatric Disorders Among Children and Adolescents Surviving Malignancies: A Nationwide Longitudinal Study.
    J Clin Oncol. 2023;41:2054-2066.
    PubMed     Abstract available


  27. YOUSSEF G, Rahman R, Bay C, Wang W, et al
    Evaluation of Standard Response Assessment in Neuro-Oncology, Modified Response Assessment in Neuro-Oncology, and Immunotherapy Response Assessment in Neuro-Oncology in Newly Diagnosed and Recurrent Glioblastoma.
    J Clin Oncol. 2023 Apr 7:JCO2201579. doi: 10.1200/JCO.22.01579.
    PubMed     Abstract available


    March 2023
  28. MUTTER JA, Alig SK, Esfahani MS, Lauer EM, et al
    Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas.
    J Clin Oncol. 2023;41:1684-1694.
    PubMed     Abstract available


    February 2023
  29. DIEZ VALLE R
    Long-Term Outcomes in Resected IDH-Mutant Subtypes of Diffuse Low-Grade Glioma.
    J Clin Oncol. 2023 Feb 28:JCO2202428. doi: 10.1200/JCO.22.02428.
    PubMed    


  30. FISHER PG
    When Can We Retire 3,600 cGy Craniospinal Irradiation in Medulloblastoma?
    J Clin Oncol. 2023 Feb 8:JCO2300008. doi: 10.1200/JCO.23.00008.
    PubMed    


  31. CHUNG J, Negm L, Bianchi V, Stengs L, et al
    Genomic Microsatellite Signatures Identify Germline Mismatch Repair Deficiency and Risk of Cancer Onset.
    J Clin Oncol. 2023;41:766-777.
    PubMed     Abstract available


  32. ZHAO B, Wu J, Li H, Ma W, et al
    Final Report of EORTC 26951 and RTOG 9402 for Anaplastic Oligodendroglial Tumors.
    J Clin Oncol. 2023;41:933-934.
    PubMed    


    January 2023
  33. COLTIN H, Pequeno P, Liu N, Tsang DS, et al
    The Burden of Surviving Childhood Medulloblastoma: A Population-Based, Matched Cohort Study in Ontario, Canada.
    J Clin Oncol. 2023 Jan 25:JCO2202466. doi: 10.1200/JCO.22.02466.
    PubMed     Abstract available


  34. GROMMES C
    Circulating Tumor DNA in the Blood: A New Frontier in Primary CNS Lymphoma?
    J Clin Oncol. 2023 Jan 20:JCO2202605. doi: 10.1200/JCO.22.02605.
    PubMed    


  35. PLATTEN M, Grassl N
    Vaccines Targeting Gliomas: Antigens Matter.
    J Clin Oncol. 2023 Jan 9:JCO2202616. doi: 10.1200/JCO.22.02616.
    PubMed    


  36. HERVEY-JUMPER SL, Zhang Y, Phillips JJ, Morshed RA, et al
    Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma.
    J Clin Oncol. 2023 Jan 4:JCO2102929. doi: 10.1200/JCO.21.02929.
    PubMed     Abstract available


    December 2022
  37. ERKER C, Mynarek M, Bailey S, Mazewski CM, et al
    Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study.
    J Clin Oncol. 2022 Dec 22:JCO2102968. doi: 10.1200/JCO.21.02968.
    PubMed     Abstract available


  38. AHLUWALIA MS, Reardon DA, Abad AP, Curry WT, et al
    Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma.
    J Clin Oncol. 2022 Dec 15:JCO2200996. doi: 10.1200/JCO.22.00996.
    PubMed     Abstract available


    November 2022
  39. YANG JT, Wijetunga NA, Pentsova E, Wolden S, et al
    Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis.
    J Clin Oncol. 2022;40:3858-3867.
    PubMed     Abstract available


  40. BOUFFET E, Geoerger B, Moertel C, Whitlock JA, et al
    Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric BRAF V600-Mutant Low-Grade Glioma.
    J Clin Oncol. 2022 Nov 14:JCO2201000. doi: 10.1200/JCO.22.01000.
    PubMed     Abstract available


    October 2022
  41. BRASTIANOS PK, Twohy EL, Gerstner ER, Kaufmann TJ, et al
    Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations.
    J Clin Oncol. 2022 Oct 26:JCO2102371. doi: 10.1200/JCO.21.02371.
    PubMed     Abstract available


  42. MASON WP
    Focal Adhesion Kinase as a Therapeutic Target for Meningiomas With Somatic Neurofibromatosis Type 2 Mutations.
    J Clin Oncol. 2022 Oct 26:JCO2201914. doi: 10.1200/JCO.22.01914.
    PubMed    


  43. TSIEN CI, Pugh SL, Dicker AP, Raizer JJ, et al
    NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma.
    J Clin Oncol. 2022 Oct 19:JCO2200164. doi: 10.1200/JCO.22.00164.
    PubMed     Abstract available


  44. KNISELY JPS, Fine HA
    Reirradiation for Recurrent Glioblastoma: What We Know and What We Do Not.
    J Clin Oncol. 2022 Oct 19:JCO2201785. doi: 10.1200/JCO.22.01785.
    PubMed     Abstract available


    August 2022
  45. LASSMAN AB, Hoang-Xuan K, Polley MC, Brandes AA, et al
    Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors.
    J Clin Oncol. 2022;40:2539-2545.
    PubMed     Abstract available


    July 2022
  46. HOUILLIER C, Dureau S, Taillandier L, Houot R, et al
    Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study.
    J Clin Oncol. 2022 Jul 14:JCO2200491. doi: 10.1200/JCO.22.00491.
    PubMed     Abstract available


    May 2022
  47. RAMAKRISHNA N, Anders CK, Lin NU, Morikawa A, et al
    Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Guideline Update.
    J Clin Oncol. 2022 May 31:JCO2200520. doi: 10.1200/JCO.22.00520.
    PubMed     Abstract available


  48. SOLOMON BJ, Bauer TM, Ignatius Ou SH, Liu G, et al
    Post Hoc Analysis of Lorlatinib Intracranial Efficacy and Safety in Patients With ALK-Positive Advanced Non-Small-Cell Lung Cancer From the Phase III CROWN Study.
    J Clin Oncol. 2022 May 23:JCO2102278. doi: 10.1200/JCO.21.02278.
    PubMed     Abstract available


  49. SCHIFF D, Messersmith H, Brastianos PK, Brown PD, et al
    Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline.
    J Clin Oncol. 2022 May 13:JCO2200333. doi: 10.1200/JCO.22.00333.
    PubMed     Abstract available


    February 2022
  50. MELLINGHOFF IK, Cloughesy TF
    Balancing Risk and Efficiency in Drug Development for Rare and Challenging Tumors: A New Paradigm for Glioma.
    J Clin Oncol. 2022 Feb 24:JCO2102166. doi: 10.1200/JCO.21.02166.
    PubMed     Abstract available


  51. MOHILE NA, Messersmith H, Gatson NT, Hottinger AF, et al
    Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline.
    J Clin Oncol. 2022;40:403-426.
    PubMed     Abstract available


    January 2022
  52. TSUI DCC, Camidge DR, Rusthoven CG
    Managing Central Nervous System Spread of Lung Cancer: The State of the Art.
    J Clin Oncol. 2022 Jan 5:JCO2101715. doi: 10.1200/JCO.21.01715.
    PubMed     Abstract available


    December 2021
  53. BAXTER NN, Kennedy EB, Bergsland E, Berlin J, et al
    Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update.
    J Clin Oncol. 2021 Dec 22:JCO2102538. doi: 10.1200/JCO.21.02538.
    PubMed     Abstract available


  54. VOGELBAUM MA, Brown PD, Messersmith H, Brastianos PK, et al
    Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline.
    J Clin Oncol. 2021 Dec 21:JCO2102314. doi: 10.1200/JCO.21.02314.
    PubMed     Abstract available


  55. KEILTY D, Khandwala M, Liu ZA, Papaioannou V, et al
    Hearing Loss After Radiation and Chemotherapy for CNS and Head-and-Neck Tumors in Children.
    J Clin Oncol. 2021;39:3813-3821.
    PubMed     Abstract available


    November 2021
  56. PATEL P
    My Beautiful Boy.
    J Clin Oncol. 2021;39:3515-3516.
    PubMed    


    October 2021
  57. ACHARYA S, Guo Y, Patni T, Li Y, et al
    Association Between Brain Substructure Dose and Cognitive Outcomes in Children With Medulloblastoma Treated on SJMB03: A Step Toward Substructure-Informed Planning.
    J Clin Oncol. 2021 Oct 29:JCO2101480. doi: 10.1200/JCO.21.01480.
    PubMed     Abstract available


  58. MAAS SLN, Stichel D, Hielscher T, Sievers P, et al
    Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated.
    J Clin Oncol. 2021 Oct 7:JCO2100784. doi: 10.1200/JCO.21.00784.
    PubMed     Abstract available


    September 2021
  59. DURNO C, Ercan AB, Bianchi V, Edwards M, et al
    Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance.
    J Clin Oncol. 2021;39:2779-2790.
    PubMed     Abstract available


    August 2021
  60. RODRIGUEZ DE DIOS N, Counago F, Murcia-Mejia M, Rico-Oses M, et al
    Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study.
    J Clin Oncol. 2021 Aug 11:JCO2100639. doi: 10.1200/JCO.21.00639.
    PubMed     Abstract available


    June 2021
  61. SANDS SA
    Patients With Pediatric Brain Tumor: When Do Their Delays Begin?
    J Clin Oncol. 2021 Jun 15:JCO2101076. doi: 10.1200/JCO.21.01076.
    PubMed    


  62. MICHALSKI JM, Janss AJ, Vezina LG, Smith KS, et al
    Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma.
    J Clin Oncol. 2021 Jun 10:JCO2002730. doi: 10.1200/JCO.20.02730.
    PubMed     Abstract available


    May 2021
  63. LIN NU, Pegram M, Sahebjam S, Ibrahim N, et al
    Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II Study.
    J Clin Oncol. 2021 May 4:JCO2002822. doi: 10.1200/JCO.20.02822.
    PubMed     Abstract available


  64. ALI JS, Ashford JM, Swain MA, Harder LL, et al
    Predictors of Cognitive Performance Among Infants Treated for Brain Tumors: Findings From a Multisite, Prospective, Longitudinal Trial.
    J Clin Oncol. 2021 May 4:JCO2001687. doi: 10.1200/JCO.20.01687.
    PubMed     Abstract available


    April 2021
  65. OYEFIADE A, Paltin I, De Luca CR, Hardy KK, et al
    Cognitive Risk in Survivors of Pediatric Brain Tumors.
    J Clin Oncol. 2021 Apr 22:JCO2002338. doi: 10.1200/JCO.20.02338.
    PubMed    


    February 2021
  66. VAN SCHAIK J, van Roessel IMAA, Schouten-van Meeteren NAYN, van Iersel L, et al
    High Prevalence of Weight Gain in Childhood Brain Tumor Survivors and Its Association With Hypothalamic-Pituitary Dysfunction.
    J Clin Oncol. 2021 Feb 23:JCO2001765. doi: 10.1200/JCO.20.01765.
    PubMed     Abstract available


    January 2021
  67. KUMAR R, Smith KS, Deng M, Terhune C, et al
    Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.
    J Clin Oncol. 2021 Jan 27:JCO2001359. doi: 10.1200/JCO.20.01359.
    PubMed     Abstract available


  68. CHEUNG IY, Cheung NV, Modak S, Mauguen A, et al
    Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease Progression.
    J Clin Oncol. 2021;39:215-226.
    PubMed     Abstract available


  69. GAJJAR A, Robinson GW, Smith KS, Lin T, et al
    Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).
    J Clin Oncol. 2021 Jan 6:JCO2001372. doi: 10.1200/JCO.20.01372.
    PubMed     Abstract available


    December 2020
  70. MCNEIL CM
    Coronavirus Farewell.
    J Clin Oncol. 2020;38:4346-4348.
    PubMed    


  71. DEKKER TJA
    Neratinib in HER2-Positive Breast Cancer With Brain Metastases.
    J Clin Oncol. 2020 Dec 17:JCO2002385. doi: 10.1200/JCO.20.02385.
    PubMed    


    October 2020
  72. GONDI V, Brown PD
    Reply to S.G. Chun et al, A. Levy et al, and N. Andratschke et al.
    J Clin Oncol. 2020;38:3455-3457.
    PubMed    


  73. ANDRATSCHKE N, Belderbos J, Mayinger M, Schagen SB, et al
    Hippocampal Avoidance and Memantine for Whole-Brain Radiotherapy: Long-Term Follow-Up Warranted.
    J Clin Oncol. 2020;38:3454-3455.
    PubMed    


  74. WEINER JP
    Reply to S.G. Chun et al.
    J Clin Oncol. 2020;38:3457-3458.
    PubMed    


  75. UPADHYAYA SA
    Relevance of the Type and Timing of Radiation Therapy to the Outcomes Reported in the ACNS0333 Trial for Atypical Teratoid/Rhabdoid Tumors.
    J Clin Oncol. 2020;38:3352.
    PubMed    


  76. REDDY AT, Krailo MD, Buxton AB, Strother DR, et al
    Reply to S.A. Upadhyaya.
    J Clin Oncol. 2020;38:3353-3354.
    PubMed    


    August 2020
  77. DAHL NA
    Sacramentality in Palliation.
    J Clin Oncol. 2020;38:2695-2696.
    PubMed    


    July 2020
  78. SAURA C, Oliveira M, Feng YH, Dai MS, et al
    Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With >/= 2 HER2-Directed Regimens: Phase III NALA Trial.
    J Clin Oncol. 2020 Jul 17:JCO2000147. doi: 10.1200/JCO.20.00147.
    PubMed     Abstract available


  79. KAHALLEY LS, Peterson R, Ris MD, Janzen L, et al
    Reply to S.A. Milgrom et al.
    J Clin Oncol. 2020;38:2212-2213.
    PubMed    


  80. MILGROM SA, Spratt DE
    Association or Causality: Does Whole Brain Proton Radiotherapy Not Impact IQ?
    J Clin Oncol. 2020;38:2211-2212.
    PubMed    


    June 2020
  81. KAYE EC, Kegel A, Weber M, Cartwright C, et al
    Food Is Love: Partnering With Families to Provide Nourishment at the End of Life.
    J Clin Oncol. 2020;38:1864-1867.
    PubMed    


    April 2020
  82. GUTIONTOV SI
    The Median Isn't the Message: Revisited.
    J Clin Oncol. 2020;38:1112-1114.
    PubMed    


    January 2020
  83. HAYDU LE, Lo SN, McQuade JL, Amaria RN, et al
    Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma.
    J Clin Oncol. 2020 Jan 28:JCO1901508. doi: 10.1200/JCO.19.01508.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.